Atlas Trials

Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery

Clinical trial NCT03446599 · WITHDRAWN

Trial details

NCT number
NCT03446599
Sponsor
Dartmouth-Hitchcock Medical Center
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
VasoplegiaHypotensionCoronary Artery DiseaseCardiac Valve Disease
Start date
2019-11-01
Primary completion
2020-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.